Oric Pharmaceuticals, Inc.
SEC Filing List
ORIC CIK: 0001796280
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G | 05/15/2026 | ||||
| SCHEDULE 13G/A | SIDLEY AUSTIN LLP /FA/ | 05/15/2026 | |||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/12/2026 | ||||
| 8-K | Current report filing | Oric Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Oric Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Oric Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/28/2026 | |
| DEF 14A | Definitive proxy statements | Oric Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/28/2026 | |
| ARS | Annual report to security holders | Oric Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/28/2026 | |
| No record found. | |||||
| Load More | |||||
